Crossmark

Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

Crossref DOI link: https://doi.org/10.1016/j.rec.2018.03.024

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lekuona, Iñaki

Anguita, Manuel

Zamorano, José Luis

Rodríguez, José Manuel

Barja de Soroa, Paloma

Pérez-Alcántara, Ferran
License Information

Text and Data Mining valid from 2019-05-01
More Information

This article is maintained by: Elsevier

Article Title: Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

Journal Title: Revista Española de Cardiología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rec.2018.03.024

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.recesp.2018.03.017

Content Type: article

Copyright: © 2018 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below